Active
Aboleris Holdco logo

Aboleris Holdco

Switched

BE0803217012

Rechtspersoon Public limited company 1 establishment

Rue Antoine de Saint-Exupéry 14, 6041 Charleroi Speur- en ontwikkelingswerk op biotechnologisch gebied aboleris-pharma.com

Active for

3 year, 2 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -5.8 million

▲ 26% vs 2024

Profit

Caution

€ -5.8 million

▲ 25% vs 2024

Debts

Low

€ 509,754

▼ 24% vs 2024

Aboleris Holdco from Charleroi, company number BE0803217012, closed financial year 2025 with a result of € -5.8 million after tax. For that financial year Aboleris Holdco recorded a gross margin of € -5.8 million and equity of € 14.3 million. Compared with financial year 2024, the result moved from € -7.8 million to € -5.8 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What happened at Aboleris Holdco?

What happened at Aboleris Holdco in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Criteria Bio Ventures SICC SA stepped down as director. NBB
  • Biotech Corporate dev stepped down as director. NBB
  • Sound Bioventures Management AB stepped down as director. NBB
  • Newton Biocapital Partners SRL stepped down as director. NBB
  • SPARAXIS SA stepped down as director. NBB
  • A.L.M. Management & Consulting SPRL stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 5.8 million. Source: NBB ↗
  • Newton Biocapital Partners SRL became a director. NBB

In short

From € 3.1 million loss in 2023 to € 5.8 million loss in 2025.

Paid € 7,806 in corporate taxes since 2023.

A new publication or filing at Aboleris Holdco? We notify you, reason included.

Follow Aboleris Holdco

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Aboleris Holdco
Aboleris Pharma 100%

It owns 100% of Aboleris Pharma itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Criteria Bio Ventures SICC SA

Director · represented by Pablo CIRONI LOPEZ

since 2024 · until 2030

since 2025 · until 2029

SPARAXIS SA

Director · represented by Caroline THIELEN

Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more

since 2023 · until 2029

Biotech Corporate dev

Director · represented by Frédéric LEGROS

since 2024 · until 2030

Sound Bioventures Management AB

Director · represented by Casper BREUM

since 2025 · until 2030

A.L.M. Management & Consulting SPRL

Director · represented by Ann MEULEMANS

Also active at: 2 BRIDGE, Healis Holding

since 2023 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Antoine de Saint-Exupéry 14

6041 Charleroi

2.346.531.651

Rue Auguste Piccard 48

6041 Charleroi

Active since 27 June 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Anime.jsApacheComplianzContact Form 7Font AwesomeGoogle AnalyticsGoogle FontsLightboxPHPSwiperWPBakeryWordPressYoast SEOjQueryreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

IONOS-AS This is the joint network for IONOS, Fasthosts, Arsys, 1&1 Mail and Media and 1&1 Telecom. Formerly known as 1&1 Internet SE., DE

Domain

Domain

aboleris-pharma.com

Registered

2018-03-24

Registrar

IONOS SE

Expires

2026-03-24

Website info

HTTPS Ja
Languages EN
Copyright 2026

Features

Webshop Blog Jobs Contact page

Security

HTTPS
SPF
DMARC

Network

IPv6

Details

Company number
0803.217.012
VAT number
BE 0803.217.012
Registered office
Rue Antoine de Saint-Exupéry 14, 6041 Charleroi
Names & denominations
Aboleris Holdco
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
27 June 2023
Peppol
Active · Active since 6 Mar 2026
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Activiteiten van hoofdkantoren

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What is the enterprise number of Aboleris Holdco?
The enterprise number of Aboleris Holdco is BE0803217012.
What is the address of Aboleris Holdco?
The registered office of Aboleris Holdco is located at Rue Antoine de Saint-Exupéry 14, 6041 Charleroi.
When was Aboleris Holdco founded?
Aboleris Holdco was founded on 27 June 2023.
What is the main activity of Aboleris Holdco?
The main activity of Aboleris Holdco is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does Aboleris Holdco have a website?
Yes, Aboleris Holdco has a website at aboleris-pharma.com.
Does Aboleris Holdco have an online shop?
Yes, Aboleris Holdco has an online shop.
Is Aboleris Holdco active on social media?
Yes, Aboleris Holdco is active on Linkedin.
How much profit did Aboleris Holdco make in 2025?
Aboleris Holdco recorded a loss after taxes of € 5,806,774 in financial year 2025.
What is the revenue of Aboleris Holdco?
As a small company, Aboleris Holdco is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -5,812,529.
Where can I find the annual accounts of Aboleris Holdco?
Aboleris Holdco files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Aboleris Holdco?
According to the 2025 annual accounts, the directors of Aboleris Holdco are: Criteria Bio Ventures SICC SA, Newton Biocapital Partners SRL, SPARAXIS SA, Biotech Corporate dev, Sound Bioventures Management AB, A.L.M. Management & Consulting SPRL.
Who owns Aboleris Holdco?
It owns 100% of Aboleris Pharma itself.